rs1557303381
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP6
The NM_004006.3(DMD):c.5324_5325delAGinsGT(p.Lys1775Ser) variant causes a missense, splice region change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004006.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.5324_5325delAGinsGT | p.Lys1775Ser | missense_variant, splice_region_variant | 1 | NM_004006.3 | ENSP00000354923.3 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Duchenne muscular dystrophy Pathogenic:1Benign:1
- -
- -
Becker muscular dystrophy Pathogenic:1
- -
Duchenne muscular dystrophy;C0917713:Becker muscular dystrophy;C3668940:Dilated cardiomyopathy 3B Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The c.5324_5325delAGinsGT variant (also known as p.K1775S), located in coding exon 37 of the DMD gene, results from an in-frame deletion of AG and insertion of GT at nucleotide positions 5324 to 5325. The lysine at codon 1775 is replaced by serine, an amino acid with dissimilar properties. However, this change also impacts the last base pair of coding exon 37, which makes it likely to have some effect on normal mRNA splicing. Based on data from gnomAD, this allele has an overall frequency of 0.003% (7/204980) total alleles studied, with 2 hemizygote(s) observed. The highest observed frequency was 0.037% (7/18995) of African alleles. These nucleotide and amino acid positions are highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may weaken the native splice donor site. In addition, as a missense substitution, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at